Atomo Diagnostics Investor Relations Material
Latest events
Q3 2025
Atomo Diagnostics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Atomo Diagnostics Limited
Access all reports
Atomo Diagnostics Limited provides products in the areas of cancer, infectious diseases, and cardiovascular ailments. Its tests include Visca for diagnosing liver cancer and liver fibrosis/cirrhosis; MammaScreen for early breast cancer detection through measurements of plasma proteins (by testing blood); Chlamydia Screen for the screening or confirmation of Chlamydia trachomatis infections; HIV-1Virology Test System for the qualitative detection of antibodies to human immunodeficiency virus type 1 (HIV-1); and AtomoRapid Malaria Test that detects malaria infection in whole blood samples. Atomo Diagnostics Limited was incorporated in 2010 and is headquartered in Leichhardt, Australia.
Key slides for Atomo Diagnostics Limited
H2 2024
Atomo Diagnostics Limited
![SOURCES
[ 1 ] Busi](https://assets.quartr.com/_next/image?url=https%3A%2F%2Fcdn.quartr.com%2Fimages%2Fconference-calls%2Fatomo-diagnostics-limited-h2-2024-fb7a1851a7a7197e%2F28.png&w=3840&q=100)
H2 2024
Atomo Diagnostics Limited
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
AT1
Country
🇦🇺 Australia